Astellas, FibroGen get extended Roxadustat approval in Japan for anemia of CKD

pharmanewsdaily- November 28, 2020 0

Roxadustat approval - Astellas Pharma and FibroGen have secured approval for EVRENZO (roxadustat) in Japan for the treatment of anemia associated with chronic kidney disease ... Read More